 |
Research & Development |
Resonance Health continues to expand its technology platform and intellectual property assets with vital research and development projets that address high clinical demand and global markets.
The multi-disciplinary R&D team at Resonance Health provides technological and knowledge-based developments related to quantitative magnetic resonance imaging (MRI) techniques for the diagnosis and clinical management of human diseases.
Research and development are being undertaken in the following key areas:
- | Fibrosis Measurement
- | Target Market: Liver Fibrosis
- | Stage: Proof of concept
- | Target date for completion of proof of concept: 1st quarter current year 2006
Following a grant from the Australian Federal Government's Biotechnology Innovation Fund (BIF), Resonance Health has made significant progress with the development of a non-invasive MRI test for liver fibrosis and has recently filed a US patent for algorithms relating to the test.
With the World Health Organisation estimating that more than 170 million people worldwide are affected by Hepatitis C, a major cause of liver fibrosis, there is a massive unmet clinical need for a new non-invasive and accurate test that quantifies fibrosis.
There is emerging evidence that iron levels may be implicated in the development of adult onset diabetes and responsiveness to therapies for several diseases, including viral hepatitis. Resonance Health is actively exploring the potential utility of FerriScan in clinical practice to better manage these disorders.
A/Prof Tim St Pierre, Chief Scientific Officer, explained the focus of the research would provide greater market opportunities and maintain Resonance Health's advantages over any emerging competitors.
'We are currently conducting ground-breaking research that leverages the technology platform established by our lead product FerriScan, to develop new applications that could potentially have a huge clinical application. Maintaining our position at the forefront of research into developments in the MRI technology related to tissue iron measurement is a core part of our continued success'.
Click here to view our published articles, research and clinical papers.
|
